We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
AUM
$859M
AUM Growth
-$429M
Cap. Flow
-$442M
Cap. Flow %
-51.43%
Top 10 Hldgs %
4.21%
Holding
1,520
New
386
Increased
181
Reduced
340
Closed
602

Top Buys

Rank Stock Value
1
GOSS icon
Gossamer Bio
GOSS
+$5.95M
2
MRVL icon
Marvell Technology
MRVL
+$4M
3
AAPL icon
Apple
AAPL
+$3.97M
4
DIS icon
Walt Disney
DIS
+$3.95M
5
ROL icon
Rollins
ROL
+$3.82M

Top Sells

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$7.11M
2
ICE icon
Intercontinental Exchange
ICE
+$6.91M
3
XRAY icon
Dentsply Sirona
XRAY
+$6.81M
4
CSCO icon
Cisco
CSCO
+$6.77M
5
QRVO icon
Qorvo
QRVO
+$6.72M

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Consumer Discretionary 16.59%
3 Industrials 13.62%
4 Financials 13.07%
5 Healthcare 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDX icon
976
Becton Dickinson
BDX
$46.9B
-4,918
Closed -$1.1M
BGC icon
977
BGC Group
BGC
$5.38B
-100,393
Closed -$315K
BKE icon
978
Buckle
BKE
$2.37B
-37,683
Closed -$1.19M
BKH icon
979
Black Hills Corp
BKH
$5.42B
-5,015
Closed -$340K
BKU icon
980
Bankunited
BKU
$3.4B
-38,892
Closed -$1.33M
BL icon
981
BlackLine
BL
$1.92B
-5,002
Closed -$300K
BLD
982
DELISTED
TopBuild
BLD
-3,268
Closed -$539K
BLDR icon
983
Builders FirstSource
BLDR
$7.8B
-27,740
Closed -$1.63M
BLFS icon
984
BioLife Solutions
BLFS
$1.59B
-35,147
Closed -$800K
BLFY
985
DELISTED
Blue Foundry Bancorp
BLFY
-14,281
Closed -$159K
BLK icon
986
Blackrock
BLK
$175B
-6,106
Closed -$3.36M
BLND icon
987
Blend Labs
BLND
$467M
-159,195
Closed -$352K
BOLT icon
988
Bolt Biotherapeutics
BOLT
$7.65M
-1,269
Closed -$38K
BRK.B icon
989
Berkshire Hathaway Class B
BRK.B
$1.11T
-5,762
Closed -$1.54M
BRKL
990
DELISTED
Brookline Bancorp
BRKL
-29,312
Closed -$341K
BRO icon
991
Brown & Brown
BRO
$24B
-54,655
Closed -$3.31M
BRY
992
DELISTED
Berry Corp
BRY
-19,672
Closed -$148K
BUR icon
993
Burford Capital
BUR
$931M
-31,878
Closed -$239K
BUSE icon
994
First Busey Corp
BUSE
$2.6B
-19,462
Closed -$428K
BWA icon
995
BorgWarner
BWA
$13B
-15,025
Closed -$415K
BXC icon
996
BlueLinx
BXC
$471M
-5,565
Closed -$346K
BY icon
997
Byline Bancorp
BY
$1.81B
-13,483
Closed -$273K
BYND icon
998
Beyond Meat
BYND
$327M
-198,571
Closed -$2.81M
CACC icon
999
Credit Acceptance
CACC
$5.99B
-1,122
Closed -$491K
CADE
1000
DELISTED
Cadence Bank
CADE
-8,199
Closed -$208K

Similar funds

Occudo Quantitative Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Occudo Quantitative Strategies held 1,520 positions worth $859M, down 33% from $1.29B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Occudo Quantitative Strategies withdrew a net $442M in Q4 2022, closing 602 positions and reducing 340 holdings. Its most notable exit was Datadog, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Occudo Quantitative Strategies opened a new position in Marvell Technology worth $3.63M.

  • Occudo Quantitative Strategies's largest Q4 2022 buy was Marvell Technology: 97,934 shares worth $3.63M.
  • Occudo Quantitative Strategies added most to Gossamer Bio in Q4 2022, an estimated $5.95M increase.
  • Occudo Quantitative Strategies's biggest Q4 2022 reduction was Align Technology, cutting an estimated $6.27M.
  • Occudo Quantitative Strategies fully exited Datadog in Q4 2022, selling an estimated $7.11M.
  • Occudo Quantitative Strategies's ten largest holdings make up 4.2% of its $859M portfolio in Q4 2022.
  • Occudo Quantitative Strategies opened 386 new positions and closed 602 in Q4 2022.
  • Occudo Quantitative Strategies's portfolio value fell 33% quarter-over-quarter to $859M.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.